PDT Partners LLC bought a new position in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 42,145 shares of the financial services provider’s stock, valued at approximately $1,044,000.
Other institutional investors also recently bought and sold shares of the company. Thrivent Financial for Lutherans boosted its stake in shares of Trupanion by 1.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after acquiring an additional 282 shares in the last quarter. EP Wealth Advisors LLC raised its stake in shares of Trupanion by 2.9% in the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after acquiring an additional 292 shares in the last quarter. Illinois Municipal Retirement Fund raised its stake in shares of Trupanion by 2.3% in the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after acquiring an additional 406 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Trupanion by 2.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock worth $1,258,000 after purchasing an additional 725 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Trupanion by 3.8% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after purchasing an additional 737 shares during the last quarter.
Insider Transactions at Trupanion
In related news, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the transaction, the executive vice president owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Margaret Tooth sold 978 shares of the company’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the transaction, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 15,116 shares of company stock worth $395,999. Insiders own 5.58% of the company’s stock.
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same period in the previous year, the business posted $0.22 EPS. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. Research analysts predict that Trupanion, Inc. will post 0.63 earnings per share for the current year.
Analysts Set New Price Targets
Several equities analysts have commented on the company. Stifel Nicolaus increased their price target on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a report on Wednesday, July 15th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $45.00 to $32.00 in a research note on Wednesday. Finally, Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $39.20.
Read Our Latest Stock Analysis on Trupanion
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
- Five stocks we like better than Trupanion
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
